4,0
11. Feb. 2025
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good pay and great people. Training was thorough Cool technology Good Benefits
Kontras
Acquired by Boston scientific sr leadership being phased out and Boston staff put in High expectations for clinical a to drive sale with no commission. A LARGE amount of patient interaction tons of phone calls